Thus, constitutive activation of the oncogenic mutant BRAFV600E, occurring in 50% of melanomas, represses the MITF/PGC-1α axis and, in turn, lowers mitochondrial OXPHOS [45]. Here, PPARGC1A is linked to melanoma.